Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma

: Mariniello, Katia; Pittaway, James F. H.; Altieri, Barbara; Borges, Kleiton Silva; Hadjidemetriou, Irene; Ribeiro, Claudio; Ruiz-Babot, Gerard; Tourigny, David S.; Lim, Jiang A.; Foster, Julie; Cleaver, Julie; Sosabowski, Jane; Rahman, Nafis; Doroszko, Milena; Hantel, Constanze; Sigala, Sandra; Abate, Andrea; Tamburello, Mariangela; Kiseljak-Vassiliades, Katja; Wierman, Margaret; Hall, Charlotte; Parvanta, Laila; Abdel-Aziz, Tarek E.; Chung, Teng-Teng; Marco, Aimee Di; Palazzo, Fausto; Gomez-Sanchez, Celso E.; Taylor, David R.; Rayner, Oliver; Ronchi, Cristina L.; Gaston-Massuet, Carles; Sbiera, Silviu; Drake, William M.; Rognoni, Emanuel; Kroiss, Matthias; Breault, David T.; Fassnacht, Martin; Guasti, Leonardo

Publisher: Wiley

: HOBOKEN

: 2025

: Cancer Communications

: CANCER COMMUN

: 6

: 2523-3548

DOI: https://doi.org/10.1002/cac2.70012

: https://doi.org/10.1002/cac2.70012

: https://research.utu.fi/converis/portal/detail/Publication/484941225

Cancer Communications - 2025 - Mariniello - Dlk1 is a novel adrenocortical stem progenitor cell marker that predicts.pdf

:
This work was supported by the MRC (MR/X021017/1, MR/S022155/1), BBSRC (BB/V007246/1), Barts Charity (MGU0436), Rosetrees Trust (M355-F1), The Medical College of Saint Bartholomew's Hospital Trust, the German Research Foundation (Deutsche Forschungsgemeinschaft, 314061271), and the National Institutes of Health Physician-Scientist Career Development Award (R01DK123694).